215
Views
1
CrossRef citations to date
0
Altmetric
Pages 127-140 | Received 09 Oct 2019, Accepted 19 Feb 2020, Published online: 18 Mar 2020

References

  • Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299(6):656. doi:10.1001/jama.299.6.656.
  • Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation–United States, 2010-2012. MMWR Morbidity Mortality Weekly Report. 2013;62(44):869–873.
  • Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21–34. doi:10.1111/head.12482.
  • Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in united states adults: results of an internet-based survey. J Pain. 2010;11(11):1230–1239. doi:10.1016/j.jpain.2010.07.002.
  • Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain. 2009;144(1):20–27. doi:10.1016/j.pain.2009.01.026.
  • Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidem Drug Safe. 2009;18(12):1166–1175. doi:10.1002/pds.1833.
  • Sullivan MD, Edlund MJ, Fan M-Y, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and medicaid insurance plans: the TROUP study. Pain. 2008;138(2):440–449. doi:10.1016/j.pain.2008.04.027.
  • Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage. 2008;36(3):280–288. doi:10.1016/j.jpainsymman.2007.10.003.
  • Thornton JD, Dwibedi N, Scott V, et al. Predictors of transitioning to incident chronic opioid therapy among working-age adults in the United States. Am Health Drug Benefits. 2018;11(1):12–21.
  • Martin BC, Fan M-Y, Edlund MJ, DeVries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26(12):1450–1457. doi:10.1007/s11606-011-1771-0.
  • Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med. 2015;162(4):276. doi:10.7326/M14-2559.
  • Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain. Clin J Pain. 2008;24(6):469–478. doi:10.1097/AJP.0b013e31816b2f26.
  • Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174(11):1589–1594. doi:10.1503/cmaj.051528.
  • Kalso E, Edwards JE, Moore AR, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112(3):372–380. doi:10.1016/j.pain.2004.09.019.
  • Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain. PAIN. 2015;156(4):569–576. doi:10.1097/01.j.pain.0000460357.01998.f1.
  • Tkacz J, Pesa J, Vo L, et al. Opioid analgesic-treated chronic pain patients at risk for problematic use. Am J Managed Care. 2013;19(11):871–880.
  • Braden JB, Russo J, Fan M-Y, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010;170(16):1425–1432. doi:10.1001/archinternmed.2010.273.
  • Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care. 2011;17(1):32–40.
  • Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Social Behav. 1995;36(1):1. doi:10.2307/2137284.
  • Shepherd JG, Locke E, Zhang Q, Maihafer G. Health services use and prescription access among uninsured patients managing chronic diseases. J Community Health. 2014;39(3):572–583. doi:10.1007/s10900-013-9799-1.
  • Fleury M-J, Ngui AN, Bamvita J-M, Grenier G, Caron J. Predictors of healthcare service utilization for mental health reasons. IJERPH. 2014;11(10):10559–10586. doi:10.3390/ijerph111010559.
  • Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. https://meps.ahrq.gov/mepsweb/index.jsp. Accessed March 6, 2018.
  • Sommers J. An examination of state estimates using multiple years of data from the medical expenditure panel survey, household component. Agency for Healthcare Research and Quality Working Paper No 06004, 2006.
  • Devine JW, Farley JF, Hadsall RS. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey. Headache. 2005;45(9):1171–1180. doi:10.1111/j.1526-4610.2005.00240.x.
  • Meraya AM, Dwibedi N, Sambamoorthi U. Polypharmacy and health-related quality of life among US adults with arthritis, Medical Expenditure Panel Survey, 2010–2012. Prev Chronic Dis. 2016;13:160092. doi:10.5888/pcd13.160092.
  • Yelin E, Herrndorf A, Trupin L, Sonneborn D. A National Study of Medical Care Expenditures for musculoskeletal conditions: the impact of health insurance and managed care. Arthritis Rheumatism. 2001;44(5):1160–1169. doi:10.1002/1529-0131(200105)44:5 < 1160::AID-ANR199 > 3.0.CO;2-Y.
  • Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care. 1996;34(3):220–233. doi:10.1097/00005650-199603000-00003.
  • Baird KE. The financial burden of out-of-pocket expenses in the United States and Canada: how different is The United States? SAGE Open Med. 2016;4:205031211562379. doi:10.1177/2050312115623792.
  • Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K, Stoddard J, Ellis DE. Improved outcomes associated with medical home implementation in pediatric primary care. Pediatrics. 2009;124(1):358–364. doi:10.1542/peds.2008-2600.
  • U.S. Bureau of Labor Statistics. Consumer Price Index (CPI). https://www.bls.gov/cpi/. Published February 2020. Accessed March 2, 2020.
  • Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. Prescribed Medicines. https://meps.ahrq.gov/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-178A. Published 2015. Accessed November 22, 2018.
  • Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–494. doi:10.1016/S0167-6296(01)00086-8.
  • Belotti F, Deb P, Manning WG, Norton EC. Twopm: two-part models. Stata J. 2015;15(1):3–20. doi:10.1177/1536867X1501500102.
  • Cantoni E, Ronchetti E. A robust approach for skewed and heavy-tailed outcomes in the analysis of health care expenditures. J Health Econ. 2006;25(2):198–213. doi:10.1016/j.jhealeco.2005.04.010.
  • Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2005;6(1):93–109. doi:10.1093/biostatistics/kxh020.
  • Deb A, Sambamoorthi U, Thornton JD, Schreurs B, Innes K. Direct medical expenditures associated with Alzheimer’s and Related Dementias (ADRD) in a nationally representative sample of older adults – an excess cost approach. Agi Mental Health. 2018;22(5):619–624. doi:10.1080/13607863.2017.1286454.
  • Monheit AC. Persistence in health expenditures in the short run: prevalence and consequences. Med Care. 2003;41(7 Suppl):III-53-III-64. doi:10.1097/01.MLR.0000076046.46152.EF.
  • Chang H-Y, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Med. 2018;16(1):69.
  • Megale RZ, Deveza LA, Blyth FM, Naganathan V, Ferreira PH, McLachlan AJ, Ferreira ML. Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: a systematic review of randomized, placebo-controlled trials. J Pain. 2018;19(5):475.e1–475.e24. doi:10.1016/j.jpain.2017.12.001.
  • Pergolizzi JV, Ma L, Foster DR, Overholser BR, Sowinski KM, Taylor R Jr, Summers KH. The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. JMCP. 2014;20(5):467–476. doi:10.18553/jmcp.2014.20.5.467.
  • Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH. Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag. 2014;17(6):372–387. doi:10.1089/pop.2013.0098.
  • Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657–667. doi:10.1111/j.1526-4637.2011.01075.x.
  • Scherrer JF, Salas J, Copeland LA, Stock EM, Ahmedani BK, Sullivan MD, Burroughs T, Schneider FD, Bucholz KK, Lustman PJ, et al. Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Family Med. 2016;14(1):54–62. doi:10.1370/afm.1885.
  • Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S. Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. J Affect Disorders. 2017;218:1–7. doi:10.1016/j.jad.2017.04.026.
  • Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2017;30(4):407–417. doi:10.3122/jabfm.2017.04.170112.
  • Cunningham PJ. Explaining the increase in family financial pressures from medical bills between 2003 and 2007: do affordability thresholds change over time? Med Care Res Rev. 2011;68(3):352–366. doi:10.1177/1077558710378122.
  • Aroke H, Buchanan A, Wen X, Ragosta P, Koziol J, Kogut S. Estimating the direct costs of outpatient opioid prescriptions: a retrospective analysis of data from the Rhode Island Prescription Drug Monitoring Program. JMCP. 2018;24(3):214–224. doi:10.18553/jmcp.2018.24.3.214.
  • Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;(1):CD006605. doi:10.1002/14651858.CD006605.pub2.
  • Goertz CM, George SZ. Insurer coverage of nonpharmacological treatments for low back pain—time for a change. JAMA Netw Open. 2018;1(6):e183037. doi:10.1001/jamanetworkopen.2018.3037.
  • Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504. doi:10.1001/jamasurg.2017.0504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.